Biotech$750,000 first-year price of new Biogen drug makes it one of the costliest medicines ever By Priyanka Dayal McCluskey — Boston GlobeDec. 28, 2016 Reprints AP/Biogen Biogen’s new drug for a rare genetic disorder will cost $375,000. Unlock this article by subscribing to STAT+ and enjoy your first 30 days free! GET STARTED Log In About the Author Reprints Priyanka Dayal McCluskey — Boston Globe Tags biotechnology drug pricing
Business Bob Herman STAT Plus: Wary of changes to Medicare Advantage, health insurers put up a fight — and exaggerate the stakes
A STAT Investigation Casey Ross and Bob Herman STAT Plus: Denied by AI: How Medicare Advantage plans use algorithms to cut off care for seniors in need
Biotech Adam Feuerstein, Damian Garde and Allison DeAngelis STAT Plus: SVB, biotech’s bank of choice, just failed. It could have ripple effects